EcoDrugPlus

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSSAUG00010024665
Gene Symbol: IDH1
3 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSSAUG00010016052
Gene Symbol: IDH2
1 Cross references
186 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp], Mitochondrial

Ensembl ID : ENSSAUG00010019613
Gene Symbol: LOC115586327
3 Cross references
207 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSSAUG00010003018
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSSAUG00010024898
Gene Symbol: KDR
3 Cross references
197 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSSAUG00010014162
Gene Symbol: KIF11
3 Cross references
201 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSSAUG00010025131
Gene Symbol: KIF5B
1 Cross references
234 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSSAUG00010013793
Gene Symbol: KIF5B
3 Cross references
236 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSSAUG00010005528
Gene Symbol: LTA4H
3 Cross references
203 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSSAUG00010007290
Gene Symbol: LTB4R
1 Cross references
142 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSSAUG00010015008
Gene Symbol: LOC115573187
3 Cross references
167 Possible Orthologues:

Lutropin-Choriogonadotropic Hormone Receptor-Like

Ensembl ID : ENSSAUG00010026589
Gene Symbol: LOC115570729
3 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).